Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2000
06/28/2000EP1012282A1 Cysteine rich receptors-train
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012280A1 Trimerising module
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012277A2 Syndecan interacting proteins and the use thereof
06/28/2000EP1012275A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012270A2 Kay - a novel immune system protein
06/28/2000EP1012267A2 An antisense oligonucleotide preparation method
06/28/2000EP1012262A1 Human frezzled-like protein
06/28/2000EP1012261A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012260A1 Interleukin-20
06/28/2000EP1012259A2 Tumor targeted vector
06/28/2000EP1012240A2 Cancer immunotherapy with semi-allogeneic cells
06/28/2000EP1012236A1 Retrovirus and viral vectors
06/28/2000EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence
06/28/2000EP1012229A1 Regulators of ucp2 gene expression
06/28/2000EP1012179A2 Cysteine rich receptors: trail
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1011735A1 METHOD OF $i(IN VIVO) TRANSFORMATION UTILIZING LIPID VEHICLES
06/28/2000EP1011734A1 Gene therapy vehicle comprising dermal sheath tissue
06/28/2000EP1011733A1 Compositions and methods for enhancing delivery of therapeutic agents to cells
06/28/2000EP1011732A1 Lineage-restricted neuronal precursors
06/28/2000EP1011731A1 Lipid a 4' kinase
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011634A1 Preparation of pharmaceutical compositions
06/28/2000EP1011457A1 Stent lining
06/28/2000EP1011330A1 Central nervous system axon regeneration
06/28/2000EP1011320A1 Transplacental delivery of oligonucleotides
06/28/2000EP0866719B1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product
06/28/2000EP0707655B1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
06/28/2000CN1258319A Vector
06/27/2000US6080849 Mutant salmonella species with a genetically engineered msbb gene, expresses altered lipid a, has reduced induction of tumor necrosis factor and increased sensitivity to chelating agents; for agents against solid tumors
06/27/2000US6080841 Human induced tumor protein
06/27/2000US6080728 Inhibiting tumor growth
06/27/2000US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide
06/27/2000US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia
06/27/2000US6080575 Isolated nucleic acid construct for expressing a biologically active substance which is activated by an enzyme released from mammalian cells; for target cell-specific therapy for tumors and inflammation
06/27/2000US6080569 Adenovirus vectors generated from helper viruses and helper-dependent vectors
06/27/2000US6080546 Antisense modulation of MEKK5 expression
06/27/2000US6080422 Administering a lipid acceptor selected from the group consisting of large liposomes comprised of phospholipids substantially free of sterol and small acceptors. prevention of restenosis during revascularization
06/27/2000US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids
06/27/2000US6080407 Diagnostic assays for MIF
06/23/2000CA2256124A1 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
06/22/2000WO2000036118A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
06/22/2000WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036100A1 Protein kinase targeting protein
06/22/2000WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
06/22/2000WO2000036091A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000WO2000035954A1 Human g protein coupled receptor
06/22/2000WO2000035953A1 Novel g protein-coupled receptor protein and dna thereof
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035471A1 Soluble haemopoietin receptor nr6 (clf-1) and uses thereof
06/22/2000WO2000035421A2 Integrative protein-dna cochleate formulations and methods for transforming cells
06/22/2000WO2000014198A9 Isolation of human pemt2 gene and methods for diagnosing and treating liver disorders
06/22/2000WO2000014106A9 Novel bag proteins and nucleic acid molecules encoding them
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000011165A9 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
06/22/2000WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins
06/22/2000WO2000009667A9 Calcineurin-dependent control of skeletal muscle fiber type
06/22/2000WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
06/22/2000WO2000006736A3 Nucleic acids and proteins from group b streptococcus
06/22/2000WO2000004135A3 Human scad-related molecules, scrm-1 and scrm-2
06/22/2000WO2000004034A3 Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages
06/22/2000WO2000002908A3 Inhibition of alopecia
06/22/2000WO1999065937A3 Truncated apaf-1 and methods of use thereof
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355971A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355066A1 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000CA2354527A1 Integrative protein-dna cochleate formulations and methods for transforming cells
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
06/22/2000CA2353818A1 Novel g protein-coupled receptor protein and dna thereof
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/21/2000EP1010762A1 DNA constructs of blood clotting factors and P-Selectin
06/21/2000EP1009860A1 Antisense oligonucleotide inhibition of ras
06/21/2000EP1009830A1 Genetic engineering of cells to enhance healing and tissue regeneration
06/21/2000EP1009826A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof
06/21/2000EP1009823A1 Human papilloma virus inhibition by antisense oligonucleotides
06/21/2000EP1009821A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same
06/21/2000EP1009811A2 New tissue-specific calpaines, their production and their use
06/21/2000EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/21/2000EP1009768A1 Persephin and related growth factors
06/21/2000EP1009765A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt
06/21/2000EP1009763A1 Synthetic hepatitis c genes
06/21/2000EP1009753A1 Hypoxia-regulated genes
06/21/2000EP1009444A2 Compositions and methods for treating arthritis utilizing gene therapy
06/21/2000EP1009443A1 priA POLYPEPTIDES
06/21/2000EP1009442A1 Improvements in or relating to regulation of t cell activation
06/21/2000EP1009441A1 Method for the treatment of grafts
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 870